Ambiq Micro, Inc. AMBQ 深 沪
交易中 05-14 11:06:25 美东时间
71.66
+0.370
+0.52%
华盛通- 最 高73.00
- 今 开71.07
- 成交量 33.21万股
- 最 低 67.28
- 昨 收 71.29
- 总市值 15.31亿
- 52周最高 73.00
- 市盈率 静 --
- 换手率 1.55%
- 52周最低 22.12
- 委 比 -29.45%
- 总股本 2136.49万
- 历史最高 73.00
- 量 比 1.13
- 振 幅 8.02%
- 历史最低 22.12
- 每 手 1
- 风险率 5.29%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅257.14%！瑞杰金融上调InflaRx目标价至9美元，评级升至"强烈买入"
今日重点评级关注：瑞杰金融：上调InflaRx评级至"强烈买入"，目标价从7美元升至9美元；巴克莱：维持Orchestra BioMed Hldgs"超配"评级，目标价从12美元升至13美元
今天 14:32
美股牛股 | 绩优股集体走强！AMBQ飙升超45%，业绩指引远超预期；云计算企业RXT绩后大涨35%
绩优股集体走强！AMBQ飙升超45%，业绩指引远超预期；云计算企业RXT绩后大涨35%，携手AMD深化AI云服务；医疗保健企业PACS劲升近29%，公布超预期业绩同时宣布回购计划>>
05-13 18:44
Full Transcript: Ambiq Micro Q1 2026 Earnings Call
On Tuesday, Ambiq Micro (NYSE:AMBQ) discussed first-quarter financial results d...
05-13 17:13
美股大行评级 | 富国银行上调英伟达目标价从265美元升至315美元；Alamar、AEVEX获多家大行首予“买入”评级
今日重点评级关注：Needham：维持Artiva Biotherapeutics"买入"评级，目标价从18美元升至41美元；HC Wainwright & Co.：维持SAB Biotherapeutics"买入"评级，目标价从7美元升至10美元
05-13 11:46
Ambiq Micro shares are trading higher after the company reported better-than-expected Q1 financial results and issued Q2 guidance above estimates.
Ambiq Micro shares are trading higher after the company reported better-than-ex...
05-12 21:00
Ambiq Micro Sees Q2 Adj EPS $(0.29)-$(0.23) vs $(0.42) Est; Sees Sales $31.000M-$32.000M vs $25.674M Est
Second Quarter Business Outlook1Ambiq's current expectations for the quarter ending June 30, 2026, include the following:Net sales within a range of $31.0 million to $32.0 millionNon-GAAP gross margin between 45.0% and
05-12 19:33
Ambiq Micro Q1 Adj. EPS $(0.25) Beats $(0.36) Estimate, Sales $25.060M Beat $21.494M Estimate
Ambiq Micro (NYSE:AMBQ) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.36) by 30.56 percent. This is a 97.91 percent increase over losses of $(11.94) per share from the
05-12 19:32
Earnings Scheduled For May 12, 2026
Companies Reporting Before The Bell • Sionna Therapeutics (NASDAQ:SION) is proj...
05-12 19:11
Shares of semiconductor and chip-related companies are trading higher amid sympathy with Qualcomm after the company reported better-than-expected Q2 financial results.
Shares of semiconductor and chip-related companies are trading higher amid symp...
05-01 03:55
美股大行评级 | 瑞银大幅上调西部数据、希捷科技目标价！汇丰银行上调英特尔评级至"买入"，目标价从50美元升至95美元
今日重点评级关注：HC Wainwright & Co.：维持Century Therapeutics"买入"评级，目标价从2美元升至5美元；Oppenheimer：维持Climb Bio"跑赢大市"评级，目标价从10美元升至18美元
04-22 12:41
